Recombinetics is a biotechnology company that is changing the way swine models can meet the needs of preclinical drug development. Using proprietary gene editing, our goal is to have the right model for the right drug - from disease models, to humanizations, to reporter lines and beyond. Better data starts with better models.
Looking for a particular Recombinetics employee's phone or email?
The Recombinetics annual revenue was $25 million in 2026.
Justin Zenanko is the CFO of Recombinetics.
9 people are employed at Recombinetics.
Recombinetics is based in New Brighton, Minnesota.
The NAICS codes for Recombinetics are [54, 541, 5417, 54171, 541714].
The SIC codes for Recombinetics are [873, 87].